Organization

Affiliated Hospital of Nantong University

15 clinical trials

2 abstracts

Clinical trial
Pretreatment With HCQ Before Radiotherapy and Chemotherapy in Advanced NPC Patients
Status: Not yet recruiting, Estimated PCD: 2024-12-31
Clinical trial
Cohort of Universal Newborn Deafness-gene Screening in Nantong City, China
Status: Active (not recruiting), Estimated PCD: 2021-03-31
Abstract
Patient-reported outcomes of furmonertinib versus gefitinib in patients with locally advanced or metastatic, EGFR mutation-positive non-small cell lung cancer (FURLONG): A multicenter, double-blind, randomized phase 3 study.
Org: National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Harbin Medical University Cancer Hospital, Xuzhou Central Hospital, Xuzhou, China, The First Hospital of China Medical University, Shenyang, China,